Press Releases

Aragen Launches ‘ChemiSHE’, India’s First Women-Led Chemistry Synthesis Laboratory

Biognosys Group Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Disease Research Through the Development of Improved Biomarker Assays

Biognosys Group today announced a major collaboration with The Michael J. Fox Foundation for Parkinson’s Research to advance the development of highly sensitive and quantitative biomarker assays for Parkinson’s disease.

Enhanced Compliance Inc. (ECI) Appoints Khalid Raja as Senior Vice President, Strategic Growth & Advisory

Enhanced Compliance Inc. today announced the appointment of Khalid Raja (Raj) as Senior Vice President, Strategic Growth & Advisory, effective April 13, 2026.

START Strengthens Dallas-Fort Worth Leadership with Dr. Salwan Al Mutar as Director of Clinical Research

Dr. Al Mutar brings deep expertise in gastrointestinal oncology and early-phase clinical trials and will help to expand access to innovative therapies across North Texas.

Certara Appoints Dr. Britta Wagenhuber as Head of Quantitative Systems Pharmacology (QSP) Consultancy

Certara Appoints Dr. Britta Wagenhuber as Head of Quantitative Systems Pharmacology (QSP) Consultancy

Plasmidsaurus Accelerates RNA-Seq: New EU Hub and Genovis Partnership Adds Stability to Speed, Without the Ice

Plasmidsaurus has announced two transformative evolutions of its RNA-Seq ecosystem.

eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency

Innovation allows for real-time data and operational insights to advance immunology breakthroughs

Baylor Genetics Connects with Genetic Counselors to Advance Answers in Rare and Undiagnosed Disease

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will be participating in two upcoming genetic counselor conferences.

Primerdesign Partners with Origin Sciences to Create Novel Rectal Mucosal Extraction Workflow

Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases

Abselion Appoints Dale Gordon as Chair

Bioprocessing leader to drive continued commercial development and international expansion

CellCarta Secures Global Exclusivity for Biofidelity's Aspyre® Lung to Advance Targeted Lung Cancer Testing

CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.

ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests

The team at ClearNote Health strengthened its leadership team with four key additions.

Babson Diagnostics Names Web Golinkin CEO

Babson Diagnostics has appointed Web Golinkin, formerly President and Chief Commercial Officer, as CEO and a member of the board to lead the company's next phase of commercial growth for its BetterWay™ blood testing system. Outgoing CEO David Stein, Ph.D., will transition to Executive Director to focus on strategic initiatives.

Baylor Genetics Enhances Whole Genome Sequencing Test with Optical Genome Mapping and Long‑Read Sequencing as Supplemental Technologies

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, today announced enhancements to its Whole Genome Sequencing (WGS) test with the addition of optical genome mapping (OGM) and long‑read sequencing (LRS) as supplemental technologies. These advanced technologies — along with RNA sequencing — enable the company’s WGS test to go beyond standard sequencing approaches, providing a more precise view of a patient’s genome and delivering more answers to help guide patient care and outcomes.

Neuland to open commercial peptide facility as part of planned phased expansion

Abselion Establishes US Subsidiary in Cambridge, MA

Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.

Baylor Genetics to Highlight New Data and Product Innovations at 2026 ACMG Annual Clinical Genetics Meeting

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, will showcase its latest scientific studies and product innovations at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting on March 10-14 in Baltimore, MD. The company will highlight its innovative portfolio at booth #1017 and share a series of presentations and poster sessions throughout the meeting.

Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings

Following Proscia’s Global Best in KLAS win in Europe, Concentriq is now the highest-rated digital pathology platform across multiple regions

Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening

• Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB • Follows close of initial funding round with investment from Stephen Quake and Jay Flatley